Neuroendocrine Responses to Intravenous Tryptophan in Major Depression
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
The increases in plasma levels of prolactin (PRL) and growth hormone (GH) following intravenous administration of the 5-hydroxytryptamine precursor tryptophan (100 mg/kg) were assessed in 30 depressed patients and 30 control subjects. In depressed patients who lost less than 10 lb, PRL responses were significantly reduced compared with controls. In contrast, the PRL responses of patients with weight loss exceeding 10 lb were significantly greater than those of either controls or the other depressed patients. Growth hormone responses to tryptophan were significantly decreased in patients who lost less than 10 lb. Prolactin, but not GH, responses correlated significantly with the postdexamethasone plasma cortisol concentration; however, an apparent relationship between GH and PRL responses and suicidal behavior was probably due to the common factor of weight loss. The results suggest that depressed patients have different types of abnormal 5-hydroxytryptamine-mediated neuroendocrine responses that correlate with the presence or absence of severe weight loss and cortisol hypersecretion. Further investigations are needed to establish if these abnormalities are central to the depressive disorder or have implications for treatment response.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intravenous citalopram (an SSRI) and tryptophan challenge were found reasonably consistently to evoke reduced prolactin and growth hormone responses in depressives compared with controls (Cowen and Charig, 1987;Deakin et al. 1990;Price et al., 1991, Kapitany et al., 1999).”
From Affective Cognition and its Disruption in Mood Disorders (2011) · cites this paper as Cowen and Charig, 1987
Citations
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
Book Review: Measurement and Classification of Psychiatric Symptoms
Priest, R. G. (1975) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591577506800751 · Cited by 2,262
Carroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243
5-HIAA in the Cerebrospinal Fluid: A Biochemical Suicide Predictor?
Åsberg, M. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770100055005 · Cited by 1,445
Aggression in humans correlates with cerebrospinal fluid amine metabolites
Brown, G. L., Goodwin, F. K., Ballenger, J. C., Goyer, P. F., & Major, L. F. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90053-2 · Cited by 1,132
The determination of tryptophan in plasma, liver, and urine.
Denckla, W. D., & Dewey, H. K. (1967) · PubMed · Cited by 823
INCREASED SEROTONIN-2 BINDING SITES IN FRONTAL CORTEX OF SUICIDE VICTIMS
Stanley, M., & Mann, J. J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92590-4 · Cited by 529
Tritiated Imipramine Binding Sites Are Decreased in the Frontal Cortex of Suicides
Stanley, M., Virgilio, J., & Gershon, S. (1982) · Science · doi:10.1126/science.7079769 · Cited by 471
Leysen, J. E., Gommeren, W., Van Gompel, P., Wynants, J., Janssen, P. F., & Laduron, P. M. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12558-3 · Cited by 452
Cited by
Delgado, P. L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810170011002 · Cited by 924
Serotonergic vulnerability and depression: assumptions, experimental evidence and implications
Jans, L. A. W., Riedel, W. J., Markus, C. R., & Blokland, A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001920 · Cited by 374
Glucocorticoids and the Genesis of Depressive Illness a Psychobiological Model
Dinan, T. G. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.3.365 · Cited by 339
Affective Cognition and its Disruption in Mood Disorders
Elliott, R., Zahn, R., Deakin, J. F. W., & Anderson, I. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.77 · Cited by 330
“and growth hormone responses in depressives compared with controls (Cowen and Charig, 1987; Deakin et al. 1990; Price et al., 1991, Kapitany et al., 1999).”
BackgroundDelgado, P. L. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950110025005 · Cited by 289
Metadata
- Authors
- Cowen, P. J.
- Affiliations
- Littlemore Hospital (GB)
- Corresponding author
- Cowen, Philip J.
- ORCID
- Cowen, Philip J.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1987-11-01
- Volume
- 44
- Issue
- 11
- Pages
- 958
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2044323467
- Cited by
- 129
- References
- 54
- Citations by year
- 2025: 1 · 2012: 1
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- major depressive disorder, tryptophan, prolactin, growth hormone, neuroendocrine response, weight loss, cortisol, dexamethasone, suicidal behavior, serotonin, hypothalamic-pituitary-adrenal axis
- MeSH terms
- Adult, Aged, Benzodiazepines, Depression, Female, Humans, Hydrocortisone, Injections, Intravenous, Male, Middle Aged, Neurosecretory Systems, Osmolar Concentration, Prolactin, Sleep Stages, Growth Hormone, Tryptophan
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroendocrine Responses to Intravenous Tryptophan in Major Depression. https://app.cochat.ai/papers/10.1001/archpsyc.1987.01800230038008
- The paper
- Cowen, P. J. (1987). Neuroendocrine Responses to Intravenous Tryptophan in Major Depression. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1987.01800230038008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.